[go: up one dir, main page]

CO5700715A2 - Proceso para la preparacion de (4-hidroxi-6-oxo-tetrahidropiran-2-il)acetonitrilo y derivados del mismo - Google Patents

Proceso para la preparacion de (4-hidroxi-6-oxo-tetrahidropiran-2-il)acetonitrilo y derivados del mismo

Info

Publication number
CO5700715A2
CO5700715A2 CO05111845A CO05111845A CO5700715A2 CO 5700715 A2 CO5700715 A2 CO 5700715A2 CO 05111845 A CO05111845 A CO 05111845A CO 05111845 A CO05111845 A CO 05111845A CO 5700715 A2 CO5700715 A2 CO 5700715A2
Authority
CO
Colombia
Prior art keywords
preparation
compound
formula
tetrahidropiran
hidroxi
Prior art date
Application number
CO05111845A
Other languages
English (en)
Inventor
Daniel Mink
Wilhelmus Hubertus Joseph Boesten
Michael Wolberg
Natascha Sereinig
Original Assignee
Dsm Ip Assets Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dsm Ip Assets Bv filed Critical Dsm Ip Assets Bv
Publication of CO5700715A2 publication Critical patent/CO5700715A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)

Abstract

1.- Proceso para la preparación de un compuesto de fórmula 1: donde un compuesto de fórmula 2 en el cual X es un grupo saliente, se hace reaccionar con un ión cianuro en agua y donde el pH es subsecuentemente disminuido a un pH entre O y 5.2.- Proceso de acuerdo con la reivindicación 1 donde la concentración del ión cianuro es al menos 1mol por litro.3.- Proceso de acuerdo con la reivindicación 1 o reivindicación 2, donde la relación molar entre la cantidad total del ión cianuro y la cantidad total del compuesto de fórmula 2, está entre 0.5 y 10.4.- Proceso de acuerdo con cualquiera de las reivindicaciones 1-3, donde el compuesto de fórmula 1 es tratado primero con una base antes de hacerse reaccionar con un ión cianuro.
CO05111845A 2003-05-02 2005-11-02 Proceso para la preparacion de (4-hidroxi-6-oxo-tetrahidropiran-2-il)acetonitrilo y derivados del mismo CO5700715A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03101227 2003-05-02

Publications (1)

Publication Number Publication Date
CO5700715A2 true CO5700715A2 (es) 2006-11-30

Family

ID=33395971

Family Applications (1)

Application Number Title Priority Date Filing Date
CO05111845A CO5700715A2 (es) 2003-05-02 2005-11-02 Proceso para la preparacion de (4-hidroxi-6-oxo-tetrahidropiran-2-il)acetonitrilo y derivados del mismo

Country Status (24)

Country Link
US (1) US7423162B2 (es)
EP (1) EP1620423B1 (es)
JP (1) JP2006525323A (es)
KR (1) KR20060011984A (es)
CN (2) CN101775000B (es)
AT (1) ATE386734T1 (es)
AU (1) AU2004234308A1 (es)
BR (1) BRPI0409866A (es)
CA (1) CA2524457A1 (es)
CO (1) CO5700715A2 (es)
CY (1) CY1113498T1 (es)
DE (1) DE602004011921T2 (es)
DK (1) DK1620423T3 (es)
EA (1) EA010100B1 (es)
ES (1) ES2300769T3 (es)
IL (1) IL171539A (es)
IS (1) IS8159A (es)
NO (1) NO20055694L (es)
NZ (1) NZ543294A (es)
PL (1) PL1620423T3 (es)
SI (1) SI1620423T1 (es)
UA (1) UA83662C2 (es)
WO (1) WO2004096788A1 (es)
ZA (1) ZA200508862B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101113163B1 (ko) 2003-07-25 2012-02-17 브래드포드 파마 리미티드 스타틴, 특히 아토르바스타틴의 제조에 유용한 중간체화합물 및 그 제조방법
US7701550B2 (en) 2004-08-19 2010-04-20 Asml Netherlands B.V. Lithographic apparatus and device manufacturing method
DE102005022284A1 (de) 2005-05-13 2006-11-23 Ratiopharm Gmbh Verfahren zur Herstellung von Statinen
US8047545B2 (en) * 2007-11-07 2011-11-01 Douglas Press, Inc. Lottery-type game with rollover feature
WO2009092702A2 (en) * 2008-01-23 2009-07-30 Lek Pharmaceuticals D.D. ((2s,4r)-4,6-dihydroxytetrahydro-2h-pyran-2-yl)methyl carboxylate and process for the production thereof
SI2614057T1 (sl) * 2010-09-09 2016-03-31 Dsm Sinochem Pharmaceuticals Netherlands B.V. Soli estrov 7-amino-3,5-dihidroksi heptanojske kisline
US20130178636A1 (en) * 2010-09-16 2013-07-11 Dsm Sinochem Pharmaceuticals Netherlands B.V. Esters of hexanoic acids as intermediates for the preparation of atorvastatin
CN105669637A (zh) * 2014-11-21 2016-06-15 南京博优康远生物医药科技有限公司 一种3,5,6-取代己酸酯衍生物的制备方法
CN112501223B (zh) * 2020-11-23 2022-08-12 江苏阿尔法药业股份有限公司 制备2-((2r，4r)-4-羟基-6-氧代四氢-2h-吡喃-2-基)乙腈的方法
CN116102482A (zh) * 2022-08-17 2023-05-12 重庆普佑生物医药有限公司 一种阿托伐他汀钙的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5003080A (en) * 1988-02-22 1991-03-26 Warner-Lambert Company Process for trans-6-(2-(substituted-pyrrol-1-yl)alkyl)pryan-2-one inhibitors of cholesterol synthesis
US5097045A (en) * 1989-02-01 1992-03-17 Warner-Lambert Company Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis
NL1015744C2 (nl) * 2000-07-19 2002-01-22 Dsm Nv Werkwijze voor de bereiding van 2-(6-gesubstitueerde-1,3-dioxan-4-yl) azijnzuurderivaten.
JP2006512086A (ja) * 2002-09-20 2006-04-13 ダイヴァーサ コーポレイション スタチンおよびスタチン中間体の合成のための酵素化学的方法

Also Published As

Publication number Publication date
AU2004234308A1 (en) 2004-11-11
EP1620423A1 (en) 2006-02-01
NZ543294A (en) 2008-05-30
ZA200508862B (en) 2007-02-28
PL1620423T3 (pl) 2008-07-31
EA200501734A1 (ru) 2006-04-28
KR20060011984A (ko) 2006-02-06
JP2006525323A (ja) 2006-11-09
ATE386734T1 (de) 2008-03-15
NO20055694L (no) 2006-02-02
ES2300769T3 (es) 2008-06-16
DK1620423T3 (da) 2008-05-26
EA010100B1 (ru) 2008-06-30
BRPI0409866A (pt) 2006-05-16
DE602004011921T2 (de) 2009-02-19
WO2004096788A1 (en) 2004-11-11
CA2524457A1 (en) 2004-11-11
EP1620423B1 (en) 2008-02-20
NO20055694D0 (no) 2005-12-01
CN101775000A (zh) 2010-07-14
CN101775000B (zh) 2014-09-24
SI1620423T1 (sl) 2008-06-30
CN1780826A (zh) 2006-05-31
IL171539A (en) 2011-03-31
US20060258733A1 (en) 2006-11-16
CY1113498T1 (el) 2016-06-22
CN1780826B (zh) 2010-05-26
US7423162B2 (en) 2008-09-09
DE602004011921D1 (de) 2008-04-03
IS8159A (is) 2005-11-30
UA83662C2 (ru) 2008-08-11

Similar Documents

Publication Publication Date Title
CO5700715A2 (es) Proceso para la preparacion de (4-hidroxi-6-oxo-tetrahidropiran-2-il)acetonitrilo y derivados del mismo
GB0100610D0 (en) Improvements in or relating to organic compounds
TNSN04065A1 (en) Treatment of acute myeloid leukemia with indolinone compounds
BRPI0413785A (pt) composto, composição, e, método de tratamento de distúrbio hiperproliferativo
PA8444201A1 (es) Derivados ciclicos de sulfona
CR9145A (es) Procedimiento para intensificar la eficiencia de etaboxam
BRPI0409614A (pt) processo para a preparação de um catalisador para produção de óxido de etileno
BRPI0413740A (pt) composto ou um seu n-óxido ou seu sal farmaceuticamente aceitável, composição, e, método de tratamento de distúrbio hiperproliferativo
ATE322833T1 (de) Verwendung von delta-aminolevulinsäure für die verhütung und behandlung von infektionen mittels pathogener mikroorganismen und parasiten
NO20040388L (no) Fremgangsmåte for fremstilling av beraprost og salter derav, samt forbindelser som er mellomprodukter i fremgangsmåten
MY164438A (en) Polishing composition
MY146013A (en) Process for purifying mesotrione
MA25766A1 (fr) Procede de fabrication d'une eau riche en calcium et eau obtenue par ce procede
ATE355255T1 (de) Auflösungshemmende mittel zur herstellung von gereinigten solen
PT985661E (pt) Processo de preparacao de creatina ou de creatina monohidratada
ATE312810T1 (de) Feste zusammensetzungen für orale verabreichung die nicht-hygroskopische salze von l-karnitin und alkanoyl-l-karnitin mit taurinchlorid enthalten
HUP0400173A2 (hu) Eljárás lényegében kloritmentes, stabil vizes klór-oxigén-oldat előállítására, az eljárással előállítható klór-oxigén-oldat és annak alkalmazása
BRPI0410920A (pt) análogos de tiocarbonato e carbonato de 8-azaprostaglandina como agentes terapêuticos
EA200201100A1 (ru) Ингибиторы для приготовления очищенного насыщенного солевого раствора
RU97107191A (ru) Способ получения гидроксида алюминия
ATE551317T1 (de) Verbindungen, die die glucosenutzung stimulieren, und anwendungsverfahren
RU2003116224A (ru) Тригидрат гамма-аминобутирато-рибофлавинат железа (ii), предназначенный для улучшения развития и роста цыплят
RU2000111874A (ru) Состав для повышения нефтеотдачи
RU2003133171A (ru) Препарат для лечения туберкулеза
EA200500763A1 (ru) Композиции ифосфамида для парентерального введения и способ их получения

Legal Events

Date Code Title Description
FC Application refused